Global Oncology Nutrition Market, By Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Others), Nutrition (Enteral Nutrition, Parenteral Nutrition), Formula (Standard Formula, Elemental Formula, Specialized Formula), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Oncology Nutrition Market Analysis and Size
The rise in the prevalence of cancer is the major driver resulting in the expansion of market’s growth. Another significant factor influencing the growth rate of oncology nutrition market is the rising healthcare expenditure. Additionally, rise in the number of clinical trials, rapid product origination and increase in the focus on enteral nutrition will cushion the growth rate of oncology nutrition market. Moreover, the rise in the research and development activities and launch of new products for the nutrition of oncology patients will provide beneficial opportunities for the oncology nutrition market in the forecast period of 2023-2030. Also, developments of elemental formulas and emerging new markets will escalate the growth rate global oncology nutrition market in future.
Data Bridge Market Research analyses that the global oncology nutrition market, which was USD 1974.75 million in 2022, is expected to reach USD 3630.83 million by 2030, and is expected to undergo a CAGR of 7.91% during the forecast period 2023-2030. This indicates that the Head and Neck Cancer segment dominates the cancer type segment of the global oncology nutrition market owing to the advancements in technology. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Oncology Nutrition Market Scope and Segmentation
2023 to 2030
2021 (Customizable to 2015-2020)
Revenue in USD Million, Volumes in Units, Pricing in USD
Cancer Type (Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Blood Cancer, Breast Cancer, Lung Cancer, Others), Nutrition (Enteral Nutrition, Parenteral Nutrition), Formula (Standard Formula, Elemental Formula, Specialized Formula), Route of Administration (Oral, Parenteral), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
Market Players Covered
FMC Corporation (U.S.), Danone (India), Abbott (U.S.), Aceto (U.S.), B. Braun Melsungen AG (Germany),Baxter (U.S.), Fresenius Kabi AG (Germany),Global Health Products, Inc. (U.S.), Hormel Foods Corporation (U.S.), Mead Johnson & Company, LLC (U.S.), Meiji Holdings Co., Ltd (Japan), Nestlé S.A.( Switzerland), BioSig Technologies, Inc. (U.S.), Auris Health, Inc. (U.S.)
Cancer is characterised by the unregulated proliferation of aberrant cells. Tumor cells or malignant cells are the names given to these cells. Oncology is the branch of medicine that deals with the prevention, treatment and diagnosis of cancer. Oncology nutrition refers to the nutrition and diet that a cancer patient consumes during and after therapy. Nutrition is a crucial therapy during cancer treatment and plays a key influence in numerous aspects of cancer development. Appropriate diet can help cancer patients maintain a healthy weight and body composition, resulting in improved healing and a higher quality of life.
Global Oncology Nutrition Market Dynamics
- Increasing Prevalence of Cancer
The rising incidence of cancer worldwide is a major driver for the global oncology nutrition market. Cancer patients often experience malnutrition and weight loss due to the disease itself or its treatments, creating a demand for specialized nutrition products.
- Growing Awareness of the Importance of Nutrition in Cancer Care
There is a growing recognition among healthcare professionals about the significant impact of nutrition on cancer treatment outcomes. This has led to increased emphasis on personalized nutrition plans for cancer patients, driving the demand for oncology nutrition products.
- Focus on Supportive Care in Cancer Management
Supportive care, including nutritional support, is an integral part of comprehensive cancer management. Oncology nutrition plays a crucial role in managing treatment-related side effects, improving quality of life, and enhancing treatment outcomes.
- Advancements in Cancer Treatments
Advancements in cancer treatments, such as chemotherapy, radiation therapy, and targeted therapies, have improved survival rates. However, these treatments can cause side effects like appetite loss, taste changes, and difficulty swallowing, creating a need for specialized nutrition support.
Rising Healthcare Expenditure
Increasing healthcare expenditure, particularly in emerging economies, has led to improved access to cancer treatments and supportive care services. This has contributed to the growth of the global oncology nutrition market.
- High Cost of Specialized Oncology Nutrition Products
Oncology-specific nutrition products can be expensive compared to regular nutritional supplements. The high cost may limit affordability and accessibility, particularly in lower-income regions, leading to restricted market growth.
Limited Reimbursement Coverage
In some healthcare systems, reimbursement coverage for oncology nutrition products may be limited or non-existent. This can pose challenges for patients and healthcare providers in accessing and utilizing these specialized products, affecting market growth
This global oncology nutrition market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global oncology nutrition market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
- On July 2021, Nestlé Health Science, a leading player in the oncology nutrition market, announced the expansion of its portfolio with the launch of two new products: Resource® ThickenUp Clear Oncology and Resource ThickenUp Clear Oncology Ready-To-Drink. These products are designed to provide hydration and nutrition support for cancer patients with swallowing difficulties
- On June, 2021, Abbott, a global healthcare company, introduced ProSure Oncology in India. ProSure Oncology is a specialized nutritional supplement designed to support the nutritional needs of cancer patients undergoing treatment. It is formulated with high-quality protein, omega-3 fatty acids, and a blend of vitamins and minerals
Global Oncology Nutrition Market Scope
The global oncology nutrition market is segmented on the basis of cancer type, nutrition, and formula, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Head and Neck Cancer
- Stomach and Gastrointestinal Cancers
- Esophageal Cancer
- Pancreatic Cancer
- Liver Cancer
- Blood Cancer
- Breast Cancer
- Lung Cancer
- Enteral Nutrition
- Parenteral Nutrition
- Standard Formula
- Elemental Formula
- Specialized Formula
Route of Administration
- Specialty Clinics
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Global Oncology Nutrition Market Regional Analysis/Insights
The global oncology nutrition market is analysed and market size insights and trends are provided by country, cancer type, nutrition, formula, route of administration, end-users and distribution channel as referenced above.
The countries covered in the global oncology nutrition market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the global oncology nutrition market because of the strong base of healthcare facilities, strong presence of major players in the market, rising demand of the Oncology Nutrition products and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global oncology nutrition market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global oncology nutrition market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global oncology nutrition market. The data is available for historic period 2015-2020.
Competitive Landscape and Global Oncology Nutrition Market Share Analysis
The global oncology nutrition market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global oncology nutrition market.
Some of the major players operating in the global oncology nutrition market are:
- FMC Corporation (U.S.)
- Danone (India)
- Abbott (U.S.)
- Aceto (U.S.)
- B. Braun Melsungen AG (Germany)
- Baxter (U.S.)
- Fresenius Kabi AG (Germany)
- Global Health Products, Inc. (U.S.)
- Hormel Foods Corporation (U.S.)
- Mead Johnson & Company, LLC (U.S.)
- Meiji Holdings Co., Ltd (Japan)
- Nestlé S.A. (Switzerland)
- BioSig Technologies, Inc. (U.S.)
- Auris Health, Inc. (U.S.)